MONOBACTAMS AND TRIBACTAM
MONOBACTAMS
Developed in response to a desire for specific drugs
aimed at gram negative bacteria (as
opposed to broad acting antibiotics). Eg:
aztreonam, tigemonam
Aztreonam only binds to gram negative
PBP.
It has no real beta-lactam ring and hence is
very beta-lactamase stable.
These drugs have a very narrow spectrum and are
useful only against aerobic gram negative organisms, but they can be used
instead of aminoglycoside drugs (which also work against gram negative
bacteria) because of their far less nephrotoxic side-effect profile
Aztreonam: This drug is
a monocyclic beta-lactam (a monobactam).
Aztreonam interacts with penicillin binding proteins and induces the
formation of long filamentous bacteria.
Antimicrobial spectrum: The antimicrobial
spectrum of aztreonam differs from that of other beta-lactams. It more closely
resembles the spectrum of the aminoglycosides. Gram positive and anaerobic
bacteria are resistant. Susceptible organisms include: (It has an unusual spectrum being active only
against Gram-negative aerobic rods) Enterobacteriaceae, Pseudomonas,
Hemophillus and Neisseria. Aztreonam is resistant to the beta-lactamase
produced by gram negative organisms.
Side effects:
Generally, the drug is well tolerated. Patients
who are allergic to penicillins do not exhibit cross-reactions with aztreonam.
Toxicity is similar to that of benzyl penicillin,
with no apparent cross allergy.
These do not cause the gastrointestinal disturbances
associated with carbapenems and other broad spectrum beta lactam
antibiotics.
Their inactivity against gram positive bacteria may
lead to superinfection with yeasts and gram positive aerobes including Enterococcus spp.and S.aureus
The empirical dose in animals is 30-50mg/kg,IV every
8 hours.
It is used in
a wide variety of iinfections involving gram negative bacteria (urinary tract,
lower respiratory tract, septicemia) with success as relatively nontoxic drug in human medicine
TRIBACTAMS
They have a tricyclic structure related to that of
carbapenems.
Sanfeterinem cilexetil is the prodrug of sanfetrinem.
It has high stability to many beta lactamases and a
broad spectrum of activity similar to that of carbapenems.
Comments
Post a Comment